TNF and irritable bowel syndrome: Of note, a retrospective cohort study of a population diagnosed with inflammatory bowel disease (IBD) revealed a higher incidence of PD among IBD patients compared to healthy subjects, and exposure of these patients to anti-TNF-α therapy was associated with reduced PD incidence (Peter et al., 2018).